Marta Gorraiz

632 total citations
23 papers, 510 citations indexed

About

Marta Gorraiz is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Marta Gorraiz has authored 23 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Marta Gorraiz's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Marta Gorraiz is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). Marta Gorraiz collaborates with scholars based in Spain, United States and Uruguay. Marta Gorraiz's co-authors include Juan José Lasarte, Noëlia Casares, Pablo Sarobe, Jesús Prìeto, Sandra Hervás‐Stubbs, Francisco Borrás‐Cuesta, Laura Arribillaga, Teresa Lozano, Diana Llópiz and Cristina Mansilla and has published in prestigious journals such as The Journal of Immunology, Hepatology and Journal of Hepatology.

In The Last Decade

Marta Gorraiz

22 papers receiving 500 citations

Peers

Marta Gorraiz
Herbert A. Runnels United States
A S Ho United States
Roos A. Karssemeijer United States
Andrea De Lerma Barbaro Italy
Rabie Chelbi France
Junwei Hou China
Claudia Winzler Italy
Linfu Zhou China
Carmen Molina Cuba
Herbert A. Runnels United States
Marta Gorraiz
Citations per year, relative to Marta Gorraiz Marta Gorraiz (= 1×) peers Herbert A. Runnels

Countries citing papers authored by Marta Gorraiz

Since Specialization
Citations

This map shows the geographic impact of Marta Gorraiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Gorraiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Gorraiz more than expected).

Fields of papers citing papers by Marta Gorraiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Gorraiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Gorraiz. The network helps show where Marta Gorraiz may publish in the future.

Co-authorship network of co-authors of Marta Gorraiz

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Gorraiz. A scholar is included among the top collaborators of Marta Gorraiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Gorraiz. Marta Gorraiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Igea, Ana, et al.. (2024). Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity. Molecular Therapy. 33(1). 297–316.
2.
Casares, Noëlia, Marta Gorraiz, Patricia Sarrión, et al.. (2024). Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model. Journal for ImmunoTherapy of Cancer. 12(7). e008572–e008572. 7 indexed citations
3.
Blanco, Ester, Teresa Lozano, Eva Martišová, et al.. (2023). Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses. Cancer Letters. 561. 216139–216139. 13 indexed citations
4.
Serrano, Diego, Noëlia Casares, Marta Gorraiz, et al.. (2022). Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. Journal for ImmunoTherapy of Cancer. 10(8). e004479–e004479. 28 indexed citations
5.
Casares, Noëlia, Marta Gorraiz, Patricia Sarrión, et al.. (2022). Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy. OncoImmunology. 11(1). 2070337–2070337. 22 indexed citations
6.
Lozano, Teresa, Diego Alignani, Marta Gorraiz, et al.. (2021). TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity. Cancer Letters. 528. 45–58. 16 indexed citations
7.
Lozano, Teresa, David Cano, Marta Gorraiz, et al.. (2021). Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma. BioMed Research International. 2021(1). 8852233–8852233. 18 indexed citations
8.
Lozano, Teresa, Noëlia Casares, Marta Gorraiz, et al.. (2021). Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor. Biomedicines. 9(2). 197–197. 7 indexed citations
9.
Martišová, Eva, Erkuden Casales, María Buñuales, et al.. (2019). Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses. Molecular Therapy. 27(11). 1892–1905. 35 indexed citations
10.
Lozano, Teresa, Marta Gorraiz, Patricia Sarrión, et al.. (2019). Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies. Frontiers in Immunology. 10. 2990–2990. 18 indexed citations
11.
Vivas, Isabel, Kristina Iribarren, Teresa Lozano, et al.. (2019). Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 30(7). 1098–1105. 15 indexed citations
12.
Lozano, Teresa, Marta Pérez-González, Marta Gorraiz, et al.. (2018). Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice. Frontiers in Immunology. 9. 68–68. 14 indexed citations
13.
Lozano, Teresa, Lorea Villanueva, Marta Gorraiz, et al.. (2015). Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation. The Journal of Immunology. 195(7). 3180–3189. 52 indexed citations
14.
Arribillaga, Laura, Teresa Lozano, Francesc Rudilla, et al.. (2013). A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell ResponsesIn Vivo. BioMed Research International. 2013. 1–9. 15 indexed citations
15.
Mansilla, Cristina, Marta Gorraiz, Marta Martínez‐Avilés, et al.. (2009). Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein. Journal of Hepatology. 51(3). 520–527. 21 indexed citations
16.
Lasarte, Juan José, Noëlia Casares, Marta Gorraiz, et al.. (2007). The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo. The Journal of Immunology. 178(2). 748–756. 85 indexed citations
17.
Arribillaga, Laura, Pablo Sarobe, Ainhoa Arina, et al.. (2005). Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine. 23(27). 3493–3499. 34 indexed citations
18.
Lasarte, Juan José, Pablo Sarobe, Patricia Boya, et al.. (2003). A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage. Hepatology. 37(2). 461–470. 19 indexed citations
19.
Arribillaga, Laura, Ascensión López-Dı́az de Cerio, Pablo Sarobe, et al.. (2003). Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Journal of Hepatology. 38. 109–109. 2 indexed citations
20.
Arribillaga, Laura, Pablo Sarobe, Noëlia Casares, et al.. (2002). Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine. 21(3-4). 202–210. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert A. Runnels Breakdown of academic impact, for papers by A S Ho Breakdown of academic impact, for papers by Roos A. Karssemeijer Breakdown of academic impact, for papers by Andrea De Lerma Barbaro Breakdown of academic impact, for papers by Rabie Chelbi Breakdown of academic impact, for papers by Junwei Hou Breakdown of academic impact, for papers by Claudia Winzler Breakdown of academic impact, for papers by Linfu Zhou Breakdown of academic impact, for papers by Carmen Molina
Rankless by CCL
2026